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Abstract
Background: Antimicrobial-resistant infections result in hospital stays costing between
$18,000 and $29,000. As of 2009, Centers for Medicare and Medicaid Services no
longer upgrade payments for hospital-acquired infections. Hospital epidemiologists
monitor and document rates of individual resistant microbes in antibiogram reports.
Overall summary measures capturing resistance within a hospital may be useful.
Objectives: We applied four techniques (L1- and L2-principal component analysis
(PCA), desirability functions, and simple summary) to create summary measures of
resistance and described the four summary measures with respect to reliability,
proportion of variance explained, and clinical utility.
Methods: We requested antibiograms from hospitals participating in the University
HealthSystem Consortium for the years 2002–2008 (n=40). A clinical team selected
organism-drug resistant pairs (as resistant isolates per 1,000 patient days) based on 1)
virulence, 2) complicated or toxic therapies, 3) transmissibility, and 4) high incidence
with increasing levels of resistance. Four methods were used to create summary
scores: 1) L1- and L2-PCA: derived multipliers so that the variance explained is
maximized; 2) desirability function: transformed resistance data to be between 0 and 1;
3) simple sum: each resistance rate was added and divided by the square root of the
total number of microbes summed. Simple correlation analyses between time and each
summary score evaluated reliability. For each year, we calculated the proportion of
explained variance by dividing each summary score’s variance by the variance in the
original data. Clinical utility was checked by comparing the trends for all of the
individual microbe’s resistance rates to the trends seen in the summary scores for each
hospital.
Results: Proportion of variance explained by L1- and L2-PCA and the simple sum was
0.61, 0.62, and 0.29 respectively. Simple sum and L1- and L2-PCA summary scores
best followed the trends seen in the individual antimicrobial resistance rates; trends in
desirability function scores deviated from those seen in individual trends of
antimicrobial resistance. L1- and L2-PCA summary scores were more influenced by
MRSA rates, and the simple sum score was less influenced. Pearson correlation
coefficients revealed good reliability through time.
Conclusion: Deriving summary measures of antimicrobial resistance can be reliable
over time and explain a high proportion of variance. Infection control practitioners and
hospital epidemiologists may find the inclusion of a summary score of antimicrobial
resistance beneficial in describing the trends of overall resistance in their yearly
antibiogram reports.
Key words: antimicrobial resistance, nosocomial, MRSA, L1-PCA, summary measure,
overall burden
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Introduction
Nosocomial infections are a great burden to US hospitals and their patients, and are
major contributors to morbidity and mortality.1 In the past decades, we have seen an
increase in the number and diversity of resistant organisms.2, 3, 4, 5 Antimicrobial
exposure is a risk factor for colonization and infection with resistant microbes, and
places selective pressures on microbes to develop resistance.6, 7 US hospitals spend
an estimated $4-7 billion annually to treat patients infected with antimicrobial-resistant
organisms, and this cost is partially attributable to infected individuals’ extended
hospital visits.8, 9
In 2009, the Centers for Medicare and Medicaid Services (CMS) implemented policy
such that they will no longer pay the additional costs associated with some hospitalacquired infections (HAIs).10 With an average cost ranging from $18,000 to $29,000 per
antimicrobial-resistant infection in a hospital, it is in the best interest of a hospital to
fully understand the overall burdens and trends of resistance to appropriately allocate
infection control and antimicrobial stewardship resources.11 Hospital infection control
practitioners and epidemiologists monitor rates of resistant microbes, and document
their findings in reports of susceptibility, also known as antibiograms. Antibiogram
reports contain data on single antibiotics paired with single microbes and document
the number of susceptible isolates. While these detailed reports can elucidate trends
within particular microbes or within particular antibiotics, they fail to provide an overall
view of resistance within a hospital.
The Society for Healthcare Epidemiology of America and Infectious Diseases
Society of America Joint Committee on the Prevention of Antimicrobial Resistance
1

urged hospitals to collect data on antimicrobial use and resistance within specific
patient care areas.12 Yet, having to digest data on multiple microbes and their
resistance rates within specific patient areas impedes health practitioners’ and
consumers’ ability to comprehend a hospital’s total burden of resistance.
To overcome this barrier, methods to summarize the multitudes of data found in
hospital antibiogram reports are needed. We posit that the development of summary
measures could be used to rate and compare burdens of resistance between hospitals,
as well as trends within hospitals.

Objectives
The objectives of this research were twofold. First, we sought to apply four
techniques to create summary measures for antibiogram data. Second, we described
the properties of each summary measure including the proportion of variance
explained, reliability, and clinical utility.

Methods
Data source
We conducted an ecologic study using aggregated hospital-level data from the
University HealthSystem Consortium (UHC) database and individual antibiogram
reports from hospitals participating in UHC and volunteering such data. UHC is an
alliance of 340 academic medical centers and their affiliated hospitals, representing
roughly 90% of the nation’s non-profit academic medical centers.13 Variables recorded
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by UHC hospitals include, but are not limited to, bed size, number of patients,
International Classification of Disease (ICD-9) diagnostic and procedure codes, severity
of illness, age, and number of transplants. Aggregate hospital-level characteristics
included were mean patient age, case mix index (CMI), bed size, occupancy rate,
average length of stay, total patient days, total discharges, transplant and surgery rates
per 1,000 discharges, and the number of major and extreme severity of illness cases
per 1,000 discharges.

Antibiogram data
VCU requested antibiograms from 75 medical centers participating in UHC for
each year from 2002 to 2008. Each hospital was offered $100 per year of data shared.
At the time of analyses, not all hospitals had submitted six years of antibiogram data,
resulting in missing data. We included 51 hospitals in the analysis, with 25 hospitals
contributing at least five years of data. Each hospital used their own standards to
measure antimicrobial sensitivity and the standards were not reported to the study
investigators. A multidisciplinary team including one highly experienced hospital
epidemiologist, two infectious disease pharmacists, and two experienced
methodologists, reviewed a sample antibiogram to choose organism-drug
combinations to be included in the summary score. The organism-drug combinations
were selected to represent important pathogens due to 1) virulence (e.g., Methicillinresistant Staphylococcus aureus), 2) require complicated or toxic therapies (e.g.,
multidrug-resistant Acinetobacter), 3) transmissibility in the hospital setting (e.g.,
Vancomycin-resistant Enterococcus), and 4) high incidence with increasing levels of
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resistance (e.g., fluoroquinolone-resistant E. coli). Aggregate incident sensitivity data
was collected on the following resistant microbes: Oxacillin-resistant Staphylococcus
aureus (MRSA), Vancomycin-resistant Enterococcus (VRE) faecalis and faecium,
Imipenem-resistant Acinetobacter baumannii, Ceftriaxone-, Ciprofloxacin-, and
Levofloxacin-resistant Escherichia coli, Ceftriaxone- and Imipenem-resistant Klebsiella
pneumoniae, and Cefepime-, Ciprofloxacin–, Imipenem–, Levofloxacin– and
Piperacillin/Tazobactam-resistant Pseudomonas aeruginosa.
For each organism-drug pair, there were several options for summarizing the data:
resistance rates (per 1,000 patient days) or proportions. The decision to use rates or
proportions depends on the reason for analysis. Resistance rates were chosen over the
use of proportions because the comparison of resistance data via proportions has not
been shown to be the most accurate indicator of resistance burden.14 It could be the
case that the proportion of resistant microbes for a particular hospital is increasing over
time, however the rate of resistant microbes has kept constant.

Approach to estimating summary measures
We implemented four approaches to estimating a summary score for antimicrobial
resistance: simple summary score, desirability function, L1 principal component
analysis (L1-PCA) and L2-PCA. Each method is described below.
Simple Summary Score
The simple summary score was calculated by summing the individual antibiograms
for each hospital for each year. The simple sum methods are linear transformations of
the data; each score is a weighted sum of the resistance rates. For the simple sum, the
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multiplier for each rate is

, where m is the total number of rates being summed.

For example: If hospital A had three resistant microbes, X, Y, and Z, the simple
summary score for 2002 would be:
Q = (Rate of X in 2002/

) + (Rate of Y in 2002/

) + (Rate of Z in 2002/

)

Desirability Function
Desirability functions were estimated using standard procedures.15 The desirability
function method begins by converting each resistance rate y to a desirability d as
follows:

⎧
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where U is an upper threshold and L is a lower threshold. For this analysis, we set r = 1
for a linear desirability function. For a given hospital, once the desirability scores for
each resistance rate were calculated, the overall desirability was calculated by the
formula:

This formula for D is the geometric mean of the

resistance rate desirabilities. The overall desirability is the score for a hospital. Note
that as with the other methods, a low score is “desirable". This convention is the
opposite of the usual notion of desirability.
Principal Component Analysis (PCA)
The principal component analysis derives multipliers so that the variance explained
is maximized.16 The first principal component describes the direction of maximum
variation in the data. The location of a hospital on this line/direction is the score and is
5

an indication of its goodness or badness with respect to drug-resistant bacteria. A high
score indicates high rates of resistance. The function prcomp() in the R Environment for
Statistical Computing is used for traditional PCA. L1-PCA is a variant of PCA that is
based on finding L1-norm best-fit subspaces rather than using the traditional Euclidean
or L2 norm. Using the L1 norm provides robustness to outlier observations so that the
underlying pattern of most of the data is more likely to be captured. The L1-PCA is
implemented in C 17; code for R is available from http://www.people.vcu.edu/jpbrooks/
l1pcastar.
There are two approaches to deal with correlated data through time. First, we
estimated L1-PCA and L2-PCA functions for each year by applying the weights derived
for each hospital within that year; this method will be called the comparison method.
The comparison method allows comparisons across hospitals within a year, but does
not permit a fair evaluation of trends within a hospital across time. Second, we
selected the year 2008 to serve as the standard. With this year’s data, the L1-PCA and
L2-PCA approach was implemented; this method will be called the trend method. For
each PCA method, the summary scale was rescaled to range from 0 to 10, where lower
scores signify lower resistance rates.
Because L1-/L2-PCA summary scores included negative numbers, they were
scaled to be between 0 and 10. For L1-/L2-PCA summary scores derived using the

comparison method, we used the following formula:
Where Mini = the minimum score for year i, Maxi = the maximum score for year i, and
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x = PCA score. Using the trend method, we used the following formula:
Where Min = the minimum score over all years, Max = the maximum score over all
years, and x = PCA score.

Analytic approach
First, we calculated descriptive statistics to describe the hospital characteristics
and case mix for the UHC hospitals participating in the study. Second, we evaluated
the variance explained. For each year, we calculated the proportion of explained
variance of each of the three summary measures by dividing their variance by the
variance in the original data. Percent variance explained was not calculated for
desirability function scores because there was less variance once all data were fit
between 0 and 1, and the original scale of measurement was not preserved. The best
summary measure would have higher proportion of explained variance. For each
method, we included all of the organism-drug pairs listed above to create the summary
scores.
We also estimated the construct validity of the summary measures. Currently, there
is no gold standard for measuring the overall burden of resistance in a hospital. This
precludes us from estimating the sensitivity and specificity of the four summary
measures to a previously validated and reliable measure. Therefore, we chose five
variables that have been known to be correlated with hospital resistance and that
should correlate well with each summary measure. Occupancy rate 18, 19, length of stay
20, 21 ,

severity of illness 21, 22 , transplantation rate 23, 24 , and age 21 have all been
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associated with antimicrobial resistance. A priori, we hypothesized that these variables
would correlate with summary measures of antimicrobial resistance. Severity of illness
was provided by UHC in five different categories: no class, minimal, moderate, major,
and extreme. We collapsed the major and extreme categories because we assumed
that the patients most likely to contribute to the burden of resistance are those whose
conditions are most severe. We estimated occupancy rates for each hospital by using
data on the number of patient days and the bed size. By multiplying the bed size by the
number of days in the year, we calculated the number of possible patient days each
hospital could accommodate. Dividing the number of patient days by the number of
possible patient days estimates the occupancy rate of each hospital. We checked the
distributions for outliers and found the following: major and extreme severity of illness
cases per 1,000 discharges, transplant rate per 1,000 discharges. As such, we did not
include hospitals with major and extreme severity of illness cases per 1,000 discharges
above 110, and transplant rates per 1,000 discharges above 15 in the correlational
analyses. A correlational analysis was done between each individual correlate of
resistance and each summary measure of resistance. If the variables were normally
distributed, Pearsons’ correlations were estimated.25 For ordinal variables, Spearman
rank-order correlations were computed.26 Residual values were checked for
homoscedasticity. Lastly, the reliability of the three summary scores was evaluated by
examining a hospital’s summary score through time. For a summary score to be useful,
it should be reliable and somewhat stable from one year to the next. A correlational
analysis was conducted between year and summary score for each hospital for the
years 2002 to 2008. As a result of our incomplete data set, some hospitals had missing
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data points for this analysis. An a priori decision was made to exclude those hospitals
with more than two years of missing summary measures.

Results
Table 1 shows the hospital descriptive characteristics. Average bed size was ~538
with 164,534 patient days. The hospitals contributing antibiogram data had an average
occupancy rate of 84%. Table 2 provides the descriptive statistics on the four
summary measures for antimicrobial resistance. Through PCA analyses, MRSA rates
were found to be highly variable between hospitals. Regardless of the approach to
develop the summary score, overall antimicrobial resistance was low across all
measures. L1-/L2-PCA scores had the highest percent variance explained. For
example, the proportion of variance explained by the L1-PCA was 62% compared to
29% for the simple score. L1-/L2-PCA summary scores had similar percent variance
explained, and simple summary scores had low percent variance explained.
Simple correlational analyses revealed both L1-/L2-PCA summary scores to have
moderate non-significant positive correlations with mean length of stay and transplant
rate per 1,000 discharges, and moderate negative correlations with major and extreme
severity of illness cases per 1,000 discharges. L1-/L2-PCA were found to poorly
correlate with percent occupancy and mean age (Table 3). Desirability function scores
were found to have significant negative correlations with mean length of stay and
transplant rates per 1,000 discharges, and moderate to low, non-significant positive
correlations with severity of illness per 1,000 discharges, occupancy rate, and mean
age. The simple sum scores were found to have a significant positive correlation with
9

transplant rate per 1,000 discharges, and low, non-significant positive correlations with
severity of illness rates per 1,000 discharges, occupancy rate, mean length of stay, and
mean age.
The reliability of the summary scores of antimicrobial resistance was estimated by
looking at the strength of the correlation between the summary scores for each
hospital and time. Out of the 61 hospitals that were included in our data set, 25
provided enough antibiogram data to calculate at least five years of summary
measures using the trend method (Table 4). L1-PCA Pearson correlation coefficients
were very strong. There were minimal differences between L1-/L2-PCA Pearson
correlation coefficients. Desirability function correlation coefficients varied from those
seen with L1-/L2-PCA; some showed strong negative correlations where L1-/L2-PCA
scores showed strong positive correlations. Desirability function scores of zero for
some hospitals resulted in the summary score having an opposite or different Pearson
correlation coefficient than L1-/L2-PCA. Simple sum score correlations were similar in
strength and direction to those seen in L1-/L2-PCA scores, with only a few deviations
from similarity.
Figure 1 demonstrates the potential utility of the summary scores by including both
the trends in summary scores of antimicrobial resistance, as well as trends in individual
antimicrobial resistance for a randomly selected hospital. Overall, this hospital had
relatively stable antimicrobial resistance trends, except for fluoroquinolone-resistant E.
coli and MRSA. From 2002-2008, fluoroquinolone-resistant E. coli increased more than
400%. From 2002-2003, there were increases in all forms of resistance. For example,
from 2003-2004, there were increases in the resistance rates of four microbes, and
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decreases in two; L1-/L2-PCA and simple sum scores increased, but desirability
scores decreased. Overall, L1-/L2-PCA scores and simple sum scores showed similar
trends, however L1-/L2-PCA trends seemed to be more influenced by changes in
MRSA antimicrobial resistance rates. Figure 1 shows that from 2006-2007 there was a
sharp rise in MRSA; L1-/L2-PCA has a steeper slope than that seen with the simple
sum score.

Discussion
In the world of infectious diseases and hospital epidemiology, there is no single
measure used to describe and illustrate the overall burden of antimicrobial resistance in
a hospital. The use of a summary measure of resistance should not be thought of as a
replacement for individual antimicrobial resistance trend analysis. Rather, our aim was
to create a measure that could be used to describe the overall patient and hospital
burden of antimicrobial-resistant infections. Our data suggest that the use of a
summary measure may be a viable option for understanding a hospital’s overall burden
of antimicrobial resistance. While the approaches to developing the summary
measures have advantages and disadvantages (Table 5) that must be thoughtfully
considered before selecting the appropriate approach given the intended use of the
data, our analyses do not support the use of the desirability function.
Our construct validity analyses did demonstrate that transplant rate had a fairly
strong correlation with all summary measures. The fact that transplant rates were fairly
correlated with our summary scores suggests that the scores follow known
relationships and have a valid construct. The lack of significant correlations in the
11

construct validity analyses may be attributed to several factors. First, our data set
consisted of aggregate hospital-level data and as a result is likely to have masked
associations. Second, we could only evaluate one year of data (2008) in these analyses
due to the complexity of how the PCA and desirability summary scores were created.
This may also have restricted our ability to detect correlations. Indeed, when we
conducted the correlational analyses using data from all years with the simple sum
score, we did observe significant correlations with percent occupancy, mean length of
stay, and transplant rate. Although these findings held for the simple sum score, we do
not have evidence that the same would be true for the PCA and desirability function
scores.
For a summary score of antimicrobial resistance to be clinically useful, it must be
reliable over time. Through reliability analyses, our data showed strong correlations
between the summary measures and time for each hospital having at least five years of
summary measure data. It may well be that trends in some hospital summary scores of
resistance may be non-linear and more variable over time. The clinical utility of a
summary score of resistance that varies widely over time is minimal. Indeed, regardless
of the approach to developing a summary measure of resistance, the reliability of the
score through time appears adequate.
Ideally, a summary measure should not be heavily influenced by the resistance rate
trends of one microbe. Our analysis demonstrated that while L1-/L2-PCA summary
scores were not extremely influenced by large changes in MRSA, the simple sum
scores provided a more robust and less easily influenced measure of overall burden of
resistance. Our analyses do not support the use of a desirability function approach to
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building summary scores of antimicrobial resistance. There were several years when a
majority of the individual microbes had increased in rates of resistance, but the
desirability function scores decreased. Logically, these findings are incompatible with
characteristics sought in a summary measure of the overall burden of antimicrobial
resistance. Although the desirability function summary score of antimicrobial resistance
showed promise vis-a-vis construct validity and reliability, it failed to visually and
logically follow overall trends of antimicrobial resistance.
For tracking trends within a given hospital, the simple sum summary score may be
useful. Trends seen in the simple sum scores logically followed the overall trends seen
in the individual antimicrobial resistance rates. Having high reliability, strong construct
validity, and being able to logically provide a great measure of overall antimicrobial
resistance translates into a very useful tool for clinicians and healthcare consumers.
Lastly, the summary measure is straightforward to calculate and does not require
specialized software, other hospitals’ data, or a statistician.
The applicability of this study must be considered with the following issue in
mind. The ability to apply techniques to measure antimicrobial resistance rates
depends on available surveillance data. To our knowledge, there is only one other
voluntary surveillance system that currently exists in the US (aside from UHC): The
National Healthcare Safety Network (NHSN). The NHSN is a voluntary, internet-based
system that links all participating hospitals to one another and with other agencies
(e.g., public health departments or quality improvement organizations).27 Mandatory
reporting and surveillance systems to monitor true nationwide prevalence in resistance
has been considered and even implemented in some countries, but not in the US. The
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performance of any of the methodological approaches to creating summary measures
will rely on valid data streams.
Ultimately, summary measures of antibiotic resistance in hospitals may be of
interest to healthcare consumers. In a qualitative evaluation of healthcare consumers
perceptions of healthcare report cards,28 54% of focus group participants identified
hospital-acquired infection rates as being an important indicator for choosing a
healthcare facility. Currently, CMS provides a useful online tool that compares hospitals
based on process-of-care measures, outcome-of-care measures, and survey of
patients’ hospital experiences, but no information on nosocomial infections.29
UCompareHealthCare, an About.com health service,30 provides information regarding
infection prevention practices including information about the hospital’s use of
antibiotics under various scenarios (e.g., percent of patients whose preventative
antibiotic(s) are stopped within 24 hours after surgery) but information on antimicrobial
resistance is nonexistent. Summary measures as explored in the current study are a
first step in allowing comparisons across hospitals. Further work on risk adjustment
strategies to permit fair comparisons is warranted.
The analyses must be considered in light of several limitations. First, antibiogram
reporting standards for each hospital included in our study were not provided by
participating hospitals. If patients contribute duplicate isolates to antibiogram data,
resistant rates can be overinflated.31 Because we were analyzing different methods of
creating a summary score of overall resistance, the possible overestimation of
individual resistance rates does not threaten our conclusions. Second, all participating
hospitals may not have reported a full 12 months of antibiogram data. Data are
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accepted on a rolling basis at UHC, and are updated on a daily bases as more data are
submitted by hospitals. Because identifying hospital information was not provided, we
could not contact the hospitals to verify the completeness of the data provided to
UHC. Third, we estimated the hospital occupancy rate based on the reported number
of patient days and the number of beds. This may have been inaccurate. Fourth, only a
small number of hospitals participated and we only had aggregate hospital-level data.
The extent to which these findings are generalizable to all hospitals is unknown. Lastly,
it was not possible to conduct statistical tests to determine which summary score best
represented the overall burden of antimicrobial resistance. In the absence of a gold
standard, this approach was not feasible. Rather, we used a crude visual and logical
check to ensure that the trends in the summary scores reflected those seen in the
individual resistance rates.

Conclusions
When Charles Darwin published On the Origin of Species by Means of Natural
Selection in November, 24, 1859, he introduced the concepts of evolution, selective
pressures and survival of the fittest. The same attributes that allowed humans to evolve
from primitive beings to one of the supreme species on the planet, allow common
microbes such as Staphylococcus and Enterococci to evolve into single and multi-drug
resistant bacteria. Surveillance of antimicrobial resistance in hospitals is paramount to
ensuring the safety of a hospital’s patients and its quality of healthcare. Through the
use of antimicrobial resistance summary scores, hospital personnel can hold a better
understanding of their hospitals overall burden of antimicrobial resistance and use the
15

information to better inform their use of pharmacotherapies. Furthermore, infection
control practitioners may find the inclusion of a summary score of antimicrobial
resistance, in conjunction with individual microbe rates of resistance, beneficial in
describing the trends of overall resistance in their yearly reports. Our work posits that a
summary measure of antimicrobial resistance can be reliable over time, associated with
known correlates of antimicrobial resistance, and clinically relevant. Desirability
functions do not perform well with antimicrobial resistance rate data. PCA is a viable
approach, but may not warrant the complexity for tracking individual trends within
hospitals. Such measures depend on the availability of comprehensive resistance
surveillance systems which are not currently mandated in the US. While healthcare
consumers may desire publicly reported antimicrobial resistance rate information for
hospitals, methodological work on how to appropriately risk adjust summary measures
to allow for appropriate comparisons is needed.

16

Tables

Table 1. Descriptive statistics for UHC hospitals contributing antibiogram data in 2008 (n=61).
Comparison method.
Variable

Mean

Median

Mean Age

SD

Range

45.1

45.0

6.59

28 - 65

CMI

1.6

1.6

0.17

1.02 - 1.89

Bed Size

538

504

191.30

185 - 1156

Percent Occupancy

84.2

84.2

16.88

25.07 - 151.14

Average Length
of Stay (Days)

5.7

5.7

0.54

4.34 - 7.31

164,534

167,466

60,859

31,035 - 294,216

29,242

28,927

10,897.35

6,944 - 57,179

4.8

4.3

3.72

0 - 18.41

Surgery Rate per 1,000
Discharges

352.1

355.2

58.48

206.31 - 511.61

Major and Extreme Severity
of Illness Cases per 1,000
Discharges

59.66

56.77

18.67

32.00 - 183.65

Total Patient Days
Total Discharges
Transplant Rate per 1,000
Discharges

Table 2. Center and spread data on summary measures for n=40 hospitals in 2008.
Comparison method.
Desirability
Variable
L1-PCA
L2-PCA
Function
Simple Sum
Mean
2.86
2.90
0.35
13.88
Median

2.79

2.84

0.22

11.96

Standard Deviation

1.50

1.52

0.32

7.31

0.18 - 6.70

0.19 - 6.79

0.05 - 1.00

2.98 - 34.55

62%

61%

n/a*

29%

Range
Variance Explained

*Percent variance explained was not calculated for desirability function scores because the
data were transformed to be between 0 and 1 and the original scale of measurement was not
preserved.

17

Table 3. Correlation coefficients between summary measures and correlates of resistance for 2008 in n=40
hospitals. Comparison Method.
Desirability
L1-PCA
L2-PCA
Function
Simple Sum
Correlate of
Resistance

Corr

p

df

Corr

p

df

Corr

p

df

Corr

p

df

(Major + Extreme)

-0.17

0.31

37

-0.17

0.30

37

-0.06

0.70

37

-0.08

0.62

37

Percent Occupancy

0.02

0.91

38

0.02

0.91

38

0.09

0.59

38

0.03

0.86

38

Mean Length of Stay

0.23

0.14

38

0.23

0.15

38

0.23

0.15

38

0.38

0.02

38

Transplant Rate per
1,000 Discharges*

0.18

0.29

37

0.17

0.29

37

0.20

0.22

37

0.32

0.05

37

Mean Age
-0.03
0.87 38
-0.02
0.88 38
* Outlying observations were excluded
† Spearman correlation coefficients shown
Corr=correlation coefficient, p=p-value, df=degrees of freedom

0.01

0.97

38

-0.02

0.89

38

Severity of Illness per
1,000 Discharges*†
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Table 4. Stability of hospital antimicrobial resistance index values from 2002-2008.
Desirability
Hospital ID
L1-PCA
L2-PCA
Function
Simple Sum
Corr
# Obs
Corr
# Obs
Corr
# Obs
Corr
# Obs
1

0.89

7

0.90

7

0.88

7

0.80

7

2

0.95

6

0.95

6

-0.68

6

0.40

7

4

0.96

7

0.96

7

0.87

7

0.96

7

5

0.44

6

0.44

6

0.51

6

0.79

7

6

0.89

6

0.89

6

0.45

6

0.34

7

7

0.52

7

0.53

7

0.23

7

0.51

7

9

0.71

6

0.72

6

0.65

6

0.31

7

10

0.81

7

0.82

7

0.17

7

0.74

7

11

0.61

7

0.62

7

0.49

7

0.58

7

13

0.69

7

0.70

7

-0.85

7

0.60

7

14

-0.67

7

-0.66

7

-0.74

7

-0.77

7

15

0.83

7

0.84

7

0.23

7

0.90

7

16

-0.03

7

0.03

7

-0.63

7

-0.75

7

19

-0.86

6

-0.86

6

-0.96

6

0.72

7

23

0.19

5

0.27

5

0.59

5

-0.72

7

24

0.31

7

0.34

7

-0.20

7

-0.10

7

25

0.55

6

0.57

6

0.90

6

0.80

7

28

0.81

6

0.82

6

0.87

6

0.62

7

29

-0.83

6

-0.83

6

-0.70

6

-0.13

7

31

-0.01

6

0.01

6

-0.41

6

0.04

7

33

0.85

7

0.86

7

-0.17

7

0.64

7

34

0.89

6

0.90

6

0.60

6

0.93

7

39

0.74

5

0.75

5

0.75

5

0.94

7

41

-0.05

5

-0.05

5

-0.30

5

0.71

7

43
-0.37
5
-0.35
5
-0.61
5
0.70
Corr=correlation coefficient; Pearson correlation coefficients shown using trend method.
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Table 5. Advantages and disadvantages to different approaches to create resistance summary measures.
Summary
Measure
L1-PCA

L2-PCA

Desirability
Function

Simple Sum

Advantages

Disadvantages

•

Resistant to outliers

•

•

Principal components indicate
importance of variables

Method is uncommon and is not widely known
or tested

•

Is influenced by highly variable antimicrobial
resistance rates

•

Can calculate the proportion of
variance explained

•

Can detect emerging resistance in
a single drug, even when all resistance
rates are combined

•

Unbounded

•

Finds direction of maximum variance

•

Not resistant to outliers

•

Principal components indicate
importance of variables

•

Is influenced by highly variable antimicrobial
resistance rates

•

Can calculate the proportion
of variance explained

•

Can detect emerging resistance in
a single drug, even when all resistance
rates are combined

•

Unbounded

•

Simple to calculate

•

Poor measure of overall antimicrobial resistance

•

Cannot calculate the proportion
of variance explained

•

Does not preserve the original scale of the data

•

Scores are bound between 0 and 1

•

Requires choice of parameter r

•

Proportion of variance explained is lowest

•

Easiest measure to calculate

•

Good measure of overall
antimicrobial resistance

•

Can calculate the proportion
of variance explained

•

Unbounded

•

Can compare hospitals across time
and to each other
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Figure 1. Examining the clinical utility of the different summary measures of antimicrobial resistance for hospital #4.
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